NEW

MITA Calls for Strengthened Enforcement of Medical Device Remanufacturing

The Medical Imaging & Technology Alliance (MITA) has written a letter that calls for the U.S. Food and Drug Administration’s (FDA) to strengthen its guidance on medical device remanufacturing and urged the agency to take the necessary steps to properly enforce the...

Perlin Named President of The Joint Commission

The Board of Commissioners of The Joint Commission have announced the appointment of Dr. Jonathan B. Perlin to lead The Joint Commission as its next President and CEO. The appointment is effective March 1, 2022. Widely known for his leadership in healthcare quality...

GE Healthcare Introduces New CT System

GE Healthcare has unveiled Revolution Ascend[i] with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to...

United Imaging uCT ATLAS Earns FDA Clearance

United Imaging has announced FDA clearance for the uCT ATLAS, the latest in the company’s computed tomography (CT) portfolio of scanners and the 25th FDA clearance for the company overall.

Fujifilm Persona C Mobile Surgical C-arm 

Fujifilm Persona C Mobile Surgical C-arm 

Persona C Mobile Fluoroscopy System is an advanced C-arm solution engineered for fast, precise positioning and advanced image quality. The system is designed to make surgical imaging easier with a simplified user interface and an automated organ program to minimize dose to both the patient and staff. The C-arm system is available with 21×21 cm or 30×30 cm amorphous Silicon (aSi) flat panel detector options for ultra-low dose fluoroscopy and vascular imaging. Its dedicated radiography mode captures high quality static X-ray images to simplify procedure time acquiring pre and postoperative imaging with one system.

For more information, visit: https://healthcaresolutions-us.fujifilm.com/diagnostic-imaging/persona-c-mobile-fluoroscopy-system.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *